Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series
Crit Care
.
2020 Apr 15;24(1):148.
doi: 10.1186/s13054-020-2840-8.
Authors
Yingchun Zeng
1
,
Zhongxiang Cai
2
,
Yunyan Xianyu
2
,
Bing Xiang Yang
3
,
Ting Song
4
,
Qiaoyuan Yan
5
Affiliations
1
The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
2
Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.
3
School of Health Sciences, Wuhan University, Wuhan, Hubei Province, China. yangbingxiang@163.com.
4
The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. song.ting@163.com.
5
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China. yanqiaoyuan@163.com.
PMID:
32293518
PMCID:
PMC7156900
DOI:
10.1186/s13054-020-2840-8
No abstract available
Publication types
Letter
Comment
MeSH terms
Betacoronavirus
COVID-19
China
Coronavirus Infections
Critical Illness
Extracorporeal Membrane Oxygenation*
Humans
Pandemics
Pneumonia, Viral
Prognosis
Retrospective Studies
SARS-CoV-2